[Angiogenesis in different clinical phases of chronic myeloid leukemia].
Krasowska-Kwiecień
Aleksandra
A
Katedra i Klinika Hematologii, Collegium Medicum, Uniwersytetu Jagiellońskiego, Kraków. alkk@mp.pl
Kijowski
Jacek
J
Łukasiewicz
Ewa
E
Sacha
Tomasz
T
Foryciarz
Kajetana
K
Majka
Marcin
M
Ratajczak
Mariusz Z
MZ
Skotnicki
Aleksander B
AB
D000328:Adult; D000368:Aged; D042683:Angiopoietin-1 / Q000378:metabolism; D001853:Bone Marrow / Q000378:metabolism; D004730:Endothelium, Vascular / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism; D006801:Humans; D016209:Interleukin-8 / Q000378:metabolism; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000503:physiopathology*; D008875:Middle Aged; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism; D009389:Neovascularization, Pathologic / Q000503:physiopathology*; D010978:Platelet Factor 4 / Q000378:metabolism; D011506:Proteins / Q000627:therapeutic use; D012074:Remission Induction; D014471:Umbilical Veins / Q000473:pathology; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
D042683:Angiopoietin-1; C448783:HIAF-1 protein, human; D016209:Interleukin-8; D011506:Proteins; D042461:Vascular Endothelial Growth Factor A; D016222:Fibroblast Growth Factor 2; D010978:Platelet Factor 4; D019950:Mitogen-Activated Protein Kinase 1
Angiogeneza a stadium zaawansowania przewlekłej białaczki szpikowej.